Shire Biotech Denmark ApS: Financial statements 2012
CVR: 33358008
Source: annual report 2012, Danish Business Authority
01/01/2012 – 31/12/2012
Shire Biotech Denmark ApS (CVR 33358008) has filed annual accounts for 2012. In 2012, the company reported revenue of DKK 4,145,110 and a net result of DKK 92,990. The profit margin was 2.2%. Equity in the 2012 report amounted to DKK 328,769. The solvency ratio was 5.7%.
- Revenue
- DKK 4,145,110
- Gross Profit
- DKK 4,145,110
- Profit/Loss
- DKK 92,990
- Equity
- DKK 328,769
- Total Assets
- DKK 5,787,081
Official annual report
Keep an eye on Shire Biotech Denmark ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2012
As of May 22, 2012, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of Shire Biotech Denmark ApS.
As of May 22, 2012, A/S PSE 17 NR. 1056 has stepped down as auditor of Shire Biotech Denmark ApS.
As of February 3, 2012, Mary Christine Di Marzio has joined the board of directors of Shire Biotech Denmark ApS.
As of February 3, 2012, Lars Eric Jernestahl has left the board of directors of Shire Biotech Denmark ApS.
As of February 3, 2012, Mary Christine Di Marzio is registered as direktion of Shire Biotech Denmark ApS.
As of February 3, 2012, Lars Eric Jernestahl has stepped down as direktion of Shire Biotech Denmark ApS.
About Shire Biotech Denmark ApS
Shire Biotech Denmark ApS was a Danish company of the type Anpartsselskab based in København V, founded in 2010. The company has been dissolved on 1 April 2018. The company was registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named SHIRE DENMARK ApS and ApS STAKE NR. 1347. The company has 0 employees (2018). In 2017, the company reported a gross profit of DKK 12,675,556 and a net result of DKK 860,343 compared with DKK 775,583 the year before. Equity in the 2017 report amounted to DKK 3,207,794.